Liver metastases inhibit immunotherapy efficacy

Nat Med. 2021 Jan;27(1):25-27. doi: 10.1038/s41591-020-01190-9.

Katherine E Lindblad^{1

2

3

4}, Amaia Lujambio^{5

6

7

8}

¹ Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
² Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
³ The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴ Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵ Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. amaia.lujambio@mssm.edu.
⁶ Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. amaia.lujambio@mssm.edu.
⁷ The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. amaia.lujambio@mssm.edu.
⁸ Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA. amaia.lujambio@mssm.edu.

No abstract available

Publication types